Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (111-120 of 299) with videos related to

Pageof 30
Sort By:
American Journal of Obstetrics and Gynecology|February 1, 1989
CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantationN Ciobanu, C D Runowicz, P H Wiernik, et al.
Lasers in Surgery and Medicine|September 13, 2001
Fluorescence spectroscopy for in vivo characterization of ovarian tissueM Brewer, U Utzinger, E Silva, et al.
The Journal of Clinical Investigation|November 1, 1981
Reactivity of a monoclonal antibody with human ovarian carcinomaR C Bast, M Feeney, H Lazarus, et al.
Oncogene|December 22, 1999
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathwayX Fang, S Yu, A Eder, et al.
Journal of the National Cancer Institute|August 1, 1974
Presence of A-type and absence of C-type virus particles in a chemically induced guinea pig hepatomaV C Dunkel, R C Bast, B I Gerwin, et al.
The International Journal of Biological Markers|May 6, 1999
CA 125: the past and the futureR C Bast, F J Xu, Y H Yu, et al.
Gynecologic Oncology|February 13, 2001
Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2M Schmidt, A McWatters, R A White, et al.
Obstetrics and Gynecology|January 1, 1994
Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomasF S Liu, M F Kohler, J R Marks, et al.
Obstetrics and Gynecology|February 1, 1990
The role of peptide growth factors in epithelial ovarian cancerA Berchuck, G J Olt, L Everitt, et al.
Gynecologic Oncology|April 1, 1994
Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alphaS Wu, W A Meeker, J R Wiener, et al.
Pageof 30

Showing results (111-120 of 299) with videos related to

Sort By:
Pageof 30
American Journal of Obstetrics and Gynecology|February 1, 1989
CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantationN Ciobanu, C D Runowicz, P H Wiernik, et al.
Lasers in Surgery and Medicine|September 13, 2001
Fluorescence spectroscopy for in vivo characterization of ovarian tissueM Brewer, U Utzinger, E Silva, et al.
The Journal of Clinical Investigation|November 1, 1981
Reactivity of a monoclonal antibody with human ovarian carcinomaR C Bast, M Feeney, H Lazarus, et al.
Oncogene|December 22, 1999
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathwayX Fang, S Yu, A Eder, et al.
Journal of the National Cancer Institute|August 1, 1974
Presence of A-type and absence of C-type virus particles in a chemically induced guinea pig hepatomaV C Dunkel, R C Bast, B I Gerwin, et al.
The International Journal of Biological Markers|May 6, 1999
CA 125: the past and the futureR C Bast, F J Xu, Y H Yu, et al.
Gynecologic Oncology|February 13, 2001
Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2M Schmidt, A McWatters, R A White, et al.
Obstetrics and Gynecology|January 1, 1994
Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomasF S Liu, M F Kohler, J R Marks, et al.
Obstetrics and Gynecology|February 1, 1990
The role of peptide growth factors in epithelial ovarian cancerA Berchuck, G J Olt, L Everitt, et al.
Gynecologic Oncology|April 1, 1994
Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alphaS Wu, W A Meeker, J R Wiener, et al.
Pageof 30